acetylleucyl-leucyl-norleucinal has been researched along with kifunensine in 1 studies
| Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (kifunensine) | Trials (kifunensine) | Recent Studies (post-2010) (kifunensine) |
|---|---|---|---|---|---|
| 321 | 0 | 53 | 94 | 0 | 47 |
| Protein | Taxonomy | acetylleucyl-leucyl-norleucinal (IC50) | kifunensine (IC50) |
|---|---|---|---|
| Chain A, ALPHA1,2-MANNOSIDASE | Homo sapiens (human) | 0.2 | |
| Chain A, ALPHA1,2-MANNOSIDASE | Homo sapiens (human) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Q; Keeney, DR; Molinari, M; Zhou, Z | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and kifunensine
| Article | Year |
|---|---|
Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.
Topics: Acetylcysteine; Alkaloids; Blotting, Western; Cell Line; Cell Membrane; Cysteine Proteinase Inhibitors; Cytosol; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Enzyme Inhibitors; Glycosylation; Green Fluorescent Proteins; Humans; Immunoprecipitation; Leupeptins; Long QT Syndrome; Mutation; Potassium Channels; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Ribonucleases; Subcellular Fractions; Time Factors; Transfection; Ubiquitin | 2005 |